Development of an orally bioavailable selective inhibitor of the menin-MLL
Hai-Jing Zhong,
Wanhe Wang,
Wei Zhou,
Jia-Xin Liang,
Yung-Chi Cheng,
Dik-Lung Ma,
Chung-Hang Leung
Affiliations
Hai-Jing Zhong
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou, Guangdong 510632, China
Wanhe Wang
Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China
Wei Zhou
Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA
Jia-Xin Liang
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China
Yung-Chi Cheng
Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA; Corresponding author.
Dik-Lung Ma
Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China; Corresponding author.
Chung-Hang Leung
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China; Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Macao SAR, China; Corresponding author. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
